Presentations by Event

Presented at ID Week, San Diego, October 2017

Safety and Pharmacokinetics (PK) in Humans of Intravenous ETX2514, a β–lactamase Inhibitor (BLI) which Broadly Inhibits Ambler Class A, C, and D β–lactamases, ID Week, October 2017

J. Lickliter, K. Lawrence, J. O’Donnell, and R. Isaacs, ID Week 2017

Program(s): etx2514